mHOMR: a feasibility study of an automated system for identifying inpatients having an elevated risk of 1-year mortality.


Journal

BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984

Informations de publication

Date de publication:
12 2019
Historique:
received: 29 12 2018
revised: 14 05 2019
accepted: 24 05 2019
pubmed: 30 6 2019
medline: 19 5 2020
entrez: 30 6 2019
Statut: ppublish

Résumé

The need for clinical staff to reliably identify patients with a shortened life expectancy is an obstacle to improving palliative and end-of-life care. We developed and evaluated the feasibility of an automated tool to identify patients with a high risk of death in the next year to prompt treating physicians to consider a palliative approach and reduce the identification burden faced by clinical staff. Two-phase feasibility study conducted at two quaternary healthcare facilities in Toronto, Canada. We modified the Hospitalised-patient One-year Mortality Risk (HOMR) score, which identifies patients having an elevated 1-year mortality risk, to use only data available at the time of admission. An application prompted the admitting team when patients had an elevated mortality risk and suggested a palliative approach. The incidences of goals of care discussions and/or palliative care consultation were abstracted from medical records. Our model (C-statistic=0.89) was found to be similarly accurate to the original HOMR score and identified 15.8% and 12.2% of admitted patients at Sites 1 and 2, respectively. Of 400 patients included, the most common indications for admission included a frailty condition (219, 55%), chronic organ failure (91, 23%) and cancer (78, 20%). At Site 1 (integrated notification), patients with the notification were significantly more likely to have a discussion about goals of care and/or palliative care consultation (35% vs 20%, p = 0.016). At Site 2 (electronic mail), there was no significant difference (45% vs 53%, p = 0.322). Our application is an accurate, feasible and timely identification tool for patients at elevated risk of death in the next year and may be effective for improving palliative and end-of-life care.

Identifiants

pubmed: 31253736
pii: bmjqs-2018-009285
doi: 10.1136/bmjqs-2018-009285
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

971-979

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Pete Wegier (P)

Temmy Latner Centre for Palliative Care, Sinai Health System, Toronto, Ontario, Canada pete.wegier@sinaihealthsystem.ca jdownar@toh.ca.
Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Department of Family & Community Medicine, University of Toronto, Toronto, Ontario, Canada.

Ellen Koo (E)

Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.

Shahin Ansari (S)

Department of Decision Support, University Health Network, Toronto, Ontario, Canada.

Daniel Kobewka (D)

Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada.

Erin O'Connor (E)

Department of Emergency Medicine, University Health Network, Toronto, Ontario, Canada.
Division of Palliative Medicine, University Health Network, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Peter Wu (P)

Department of Medicine, University Health Network, Toronto, Ontario, Canada.

Leah Steinberg (L)

Temmy Latner Centre for Palliative Care, Sinai Health System, Toronto, Ontario, Canada.
Department of Family & Community Medicine, University of Toronto, Toronto, Ontario, Canada.

Chaim Bell (C)

Department of Medicine, Sinai Health System, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Tara Walton (T)

Ontario Palliative Care Network, Toronto, Ontario, Canada.

Carl van Walraven (C)

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada.
Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Gayathri Embuldeniya (G)

Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Judy Costello (J)

Department of Medical Oncology and Hematology, University Health Network, Toronto, Ontario, Canada.
Lawrence S Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.

James Downar (J)

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada pete.wegier@sinaihealthsystem.ca jdownar@toh.ca.
Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada.
Bruyère Research Institute, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH